These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8915097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H, Hüls A, Ligneau X, Purand K, Pertz H, Arrang JM, Schwartz JC, Schunack W.
    Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1998 Oct 08; 41(21):4171-6. PubMed ID: 9767653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
    Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2000 Aug 24; 43(17):3335-43. PubMed ID: 10966752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253
    [Abstract] [Full Text] [Related]

  • 12. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.
    Łazewska D, Kieć-Kononowicz K, Pertz HH, Elz S, Stark H, Schunack W.
    Pharmazie; 2002 Dec 10; 57(12):791-5. PubMed ID: 12561236
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.
    Lazewska D, Kieć-Kononowicz K, Elz S, Pertz HH, Stark H, Schunack W.
    Pharmazie; 2005 Jun 10; 60(6):403-10. PubMed ID: 15997826
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2004 May 06; 47(10):2678-87. PubMed ID: 15115409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
    Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1996 Mar 01; 39(5):1157-63. PubMed ID: 8676353
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.